NASDAQ: BOLT
Bolt Biotherapeutics Inc Stock Ownership - Who owns Bolt Biotherapeutics?

Insider buying vs selling

Have Bolt Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Coastlands Capital LP10% Owner2026-11-0950,000$6.38
$319.00kBuy
Grant YonehiroCOO2026-09-186,850$3.24
$22.17kSell
Sarah NemecPAO;VP2026-09-184,077$3.24
$13.19kSell
William P. QuinnCEO;CFO;Pres2026-09-189,132$3.24
$29.55kSell
Sarah NemecPAO;VP2026-09-172,922$3.32
$9.70kSell
Grant YonehiroCOO2026-09-174,909$3.32
$16.29kSell
William P. QuinnCEO;CFO;Pres2026-09-176,545$3.32
$21.72kSell
William P. QuinnCEO;CFO;Pres2026-09-161,889$3.77
$7.13kSell
Sarah NemecPAO;VP2026-09-16843$3.77
$3.18kSell
Grant YonehiroCOO2026-09-161,417$3.77
$5.35kSell

1 of 2

BOLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BOLT insiders and whales buy or sell their stock.

BOLT Shareholders

What type of owners hold Bolt Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital VIII LLC305.54%5,885,846$34.14MInsider
Holdings A. Novo192.28%3,703,991$21.48MInsider
Edgar Engleman170.96%3,293,286$19.10MInsider
James Healy142.99%2,754,437$15.98MInsider
Sofinnova Venture Partners X LP142.99%2,754,437$15.98MInsider
Mahendra Shah75.18%1,448,286$8.40MInsider
Coastlands Capital LP24.00%462,416$2.68MInsider
Sheila Gujrathi4.46%85,821$497.76kInsider
Edith A. Perez2.42%46,612$270.35kInsider
William P. Quinn1.32%25,384$147.23kInsider

1 of 3

BOLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLT0.00%100.00%Net BuyingNet Buying
ESLA0.00%67.94%Net BuyingNet Buying
NCEL0.00%24.36%Net Buying
MCRB0.00%100.00%Net SellingNet Selling
ACTU0.02%57.38%Net SellingNet Buying

Bolt Biotherapeutics Stock Ownership FAQ

Who owns Bolt Biotherapeutics?

Bolt Biotherapeutics (NASDAQ: BOLT) is owned by 0.02% institutional shareholders, 786.62% Bolt Biotherapeutics insiders, and 0.00% retail investors. Vivo Capital VIII LLC is the largest individual Bolt Biotherapeutics shareholder, owning 5.89M shares representing 225.73% of the company. Vivo Capital VIII LLC's Bolt Biotherapeutics shares are currently valued at $33.26M.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.